Abbott’s $1.9B electrophysiology unit threatened by pulsed field ablation: analysts

Pulsed field ablation (PFA) devices from Boston Scientific, Johnson & Johnson and Medtronic are a threat to Abbott’s $1.9 billion electrophysiology business, according to analysts at Stifel.